Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4028-4033

  Arnold, Susanne M ^a   Young, A Byron ^b   Munn, Rita K ^a   Patchell, Roy A ^b   Nanayakkara, Nuwan ^c   Markesbery, William R ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; PROTEIN BCL 2; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BRAIN METASTASIS; BREAST CARCINOMA; CANCER; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEGRADATION; DEREGULATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MALE; MELANOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; UTERUS CANCER;

ADULT; AGED; BRAIN NEOPLASMS; CADHERINS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM PROTEINS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033386796     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Liotta, L. A., Stetler-Stevenson, W. G., and Steeg, P. S. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Investig., 9: 543-551, 1991.
2. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-185, 1985.
3. Nicholson, G. L., Menter, D. G., Herrman, J., Cavanaugh, P., Jia, L., Hamada, J., Yun, Z., Nakajima, M., and Marchetti, D. Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors. Crit. Rev. Oncog., 5: 451-471, 1994.
4. DeClerck, Y. A., Shimada, H., Gonzales-Gomez, I., and Raffel, C. Tumoral invasion in the central nervous system. J. Neurooncol., 18: 111-121, 1994.
5. Vogelstein, B., Fearon, E. R., Hamilton, S., Kern, S., Preisinger, A., Leppert, M., Nakamura, Y., White, R., Smits, A., and Bos, J. Genetic alterations during colorectal tumor development. N. Engl. J. Med., 319: 525-532, 1988.
6. Walker, C., Robertson, L., Myskow, M., and Dixon, G. Expression of bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer, 72: 164-169, 1995.
7. Behrens, J., Lowrick, O., Klein-Hitpass, L., and Birchmeier, W. The E-cadherin promoter: final analysis of a G:C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA, 88: 11495-11499, 1991.
8. Mattijssen, V., Peters, H. M., Schalkwijk, L., Manni, J., van't Hof- Grootenboer, B., de Mulder, P., and Ruiter, D. E-cadherin expression in head and neck squamous cell carcinoma is associated with clinical outcome. Int. J. Cancer, 55: 580-585, 1993.
9. Stetler-Stevenson, W. G., Liotta, L., and Kleiner, D. E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7: 1434-1441, 1993.
10. Ennis, B. W., and Matrisian, L. M. Matrix degrading metalloproteinases. J. Neurooncol., 18: 105-109, 1994.
11. Ashida, K., Nakatsukasa, H., Higashi, T., Ohguchi, S., Hino, N., Nouso, K., Urabe, Y., Yoshida, K., Kinugasa, N., and Tsuji, T. Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma. Am. J. Pathol., 149: 1803-1811, 1996.
12. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
13. Patchell, R. A., Tibbs, P. A., Walsh, J., Dempsey, R., Maruyama, Y., Kryschio, R., Markesbery, W., MacDonald, J., and Young, B. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med., 322: 494-500, 1990.
14. Hsu, S-M., Raine, L., and Finger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem., 29: 577-580, 1981.
15. Ebina, E., Steinberg, S., Mulshine, J., and Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496-2503, 1994.
16. Michalides, R., Hagemen, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, J. A clinicopathologic study of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer, 73: 728-734, 1996.
17. Zschiesche, W., Schonborn, I., Beherens, J., Herrenknecht, K., Hartveit, F., Lilleng, P., and Birchmeier, W. Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res., 17: 561-568, 1997.
18. Sjogren, S., Inganas, M., Norberg, T., Lindgren, A., Nordgren, H., Holmberg, L., and Bergh, J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. Natl. Cancer Inst., 88: 173-182, 1996.
19. Nakagawa, T., Kubota, T., Kabuto, M., Sato, K., Kawano, H., Hayakawa, T., and Okada, Y. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg., 81: 69-77, 1994.
20. Haas-Kogan, D. A., Kogan, S. S., Yount, G., Hsu, J., Haas, M., Deen, D. F., and Israel, M. A. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J. Radiat. Oncol. Biol. Phys., 43: 399-403, 1999.
21. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M., Dunnill, M., Pierce, C., Harris, A., Gatter, K. C., and Mason, D. Bcl-2 protein in non-small cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
22. Fleming, M., Guinee, D., Chu, W. S., Freedman, A., Caporaso, N., Bennett, W., Colby, T., Tazelaar, H., Abbondanzo, S., Jett, J., Pairolero, P., Trastek, V., Liotta, L., Harris, C., and Travis, W. Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. Hum. Pathol., 29: 60-64, 1998.
23. Gee, J., Robertson, J., Ellis, I., Willsher, P., McClelland, R., Hoyle, H., Kyme, S., Finlay, P., Blamey, R., and Nicholson, R. Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer, 59: 619-628, 1994.
24. Anton, R. C., Brown, R. W., Younes, M., Gondo, M. M., Atephenson, M. A., and Cagle, P. T. Absence of prognostic signs of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. Hum. Pathol., 28: 1079-1082, 1997.
25. Korsmeyer, S. J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res., 59 (Suppl. 7): 1693s-1700s, 1999.
26. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchoi, M., Angeletti, C. A., Basolo, F., and Bevilacqua, G. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br. J. Cancer, 71: 1003-1007, 1995.